Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pandemic H5N1 Influenza”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00695669
What this trial is testing

A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64

Who this might be right for
Influenza
GlaxoSmithKline 312
Not applicableWithdrawnNCT00640302
What this trial is testing

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza

Who this might be right for
Pandemic Influenza
Kirby Institute
Early research (Phase 1)Study completedNCT00694213
What this trial is testing

Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)

Who this might be right for
Influenza
Vical 47
Large-scale testing (Phase 3)Study completedNCT00848029
What this trial is testing

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules

Who this might be right for
Pre-pandemic Influenza Vaccine
Novartis Vaccines 240
Large-scale testing (Phase 3)Study completedNCT00319098
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above

Who this might be right for
Influenza
GlaxoSmithKline 5,075
Early research (Phase 1)Study completedNCT02335164
What this trial is testing

Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults

Who this might be right for
Influenza
Vaxine Pty Ltd 270
Testing effectiveness (Phase 2)Study completedNCT01416571
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults

Who this might be right for
Influenza
GlaxoSmithKline 78
Testing effectiveness (Phase 2)Study completedNCT00900588
What this trial is testing

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd
Testing effectiveness (Phase 2)Study completedNCT00561184
What this trial is testing

Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine

Who this might be right for
Avian Influenza
Novartis Vaccines 47
Large-scale testing (Phase 3)Study completedNCT00711295
What this trial is testing

Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups

Who this might be right for
Influenza
Alachua Government Services, Inc. 3,583
Not applicableStudy completedNCT01298206
What this trial is testing

Case-control Study of Pandemic A/H1N1 Influenza Risk Factors In Lebanon

Who this might be right for
A/H1N1 InfluenzaSwine Flu
St. Jude Children's Research Hospital 129
Early research (Phase 1)Study completedNCT00922259
What this trial is testing

Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7

Who this might be right for
Influenza A
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)Study completedNCT01776541
What this trial is testing

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic H5N1 Influenza
Novartis Vaccines 979
Testing effectiveness (Phase 2)Study completedNCT05422326
What this trial is testing

Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed

Who this might be right for
Influenza, HumanInfluenza in BirdsRespiratory Tract Infections+5 more
Seqirus 260
Testing effectiveness (Phase 2)Study completedNCT00771615
What this trial is testing

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years

Who this might be right for
Influenza
GlaxoSmithKline 469
Testing effectiveness (Phase 2)Active Not RecruitingNCT07128615
What this trial is testing

A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

Who this might be right for
Influenza A
AstraZeneca 405
Early research (Phase 1)Study completedNCT00347672
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Study completedNCT00310206
What this trial is testing

H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 100
Early research (Phase 1)Study completedNCT00488046
What this trial is testing

Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 16
Large-scale testing (Phase 3)Study completedNCT02107807
What this trial is testing

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

Who this might be right for
Influenza, HumanFlu, HumanFlu, Avian+2 more
Seqirus 539
Next Page